Related Experiment Videos
Polymorphonuclear leukocyte dysregulation during the systemic inflammatory response syndrome
1Department of Surgery, Brown University School of Medicine, Rhode Island Hospital, Providence 02903.
Blood
|March 1, 1994
Summary
Polymorphonuclear leukocyte (PMN) dysfunction contributes to organ failure in systemic inflammatory response syndrome (SIRS). In severe SIRS, PMN adherence to fibronectin/laminin significantly increases function, indicating abnormal immune cell behavior.
Area of Science:
- Immunology
- Cellular Biology
- Critical Care Medicine
Background:
- Systemic inflammatory response syndrome (SIRS) can lead to organ dysfunction.
- Altered polymorphonuclear leukocyte (PMN) function is a suspected contributor to SIRS-induced organ dysfunction.
Purpose of the Study:
- To investigate whole blood PMN function in patients with acute pancreatitis, a model for SIRS.
- To assess the impact of fibronectin and laminin adherence on PMN function in mild and severe pancreatitis.
Main Methods:
- Evaluated intracellular hydrogen peroxide (H2O2) production, CD32w/CD16 expression, and phagocytosis in whole blood PMNs.
- Compared PMN function in healthy controls, mild pancreatitis patients, and severe pancreatitis patients.
- Utilized dichlorofluorescein diacetate, fluorescently labeled antibodies, and fluorescent microspheres for assays.
Main Results:
- PMN adherence to fibronectin/laminin increased function by 5-20% in controls and mild pancreatitis, but 50-75% in severe pancreatitis.
- Pertussis toxin, pentoxifylline, and dibutyryl cAMP modulated PMN function differently across groups.
- Severe pancreatitis PMNs showed exaggerated oxidative responses to NaF, partially reduced by anti-interleukin-6.
Conclusions:
- Abnormal whole blood PMN function occurs during SIRS when adhering to fibronectin or laminin.
- This abnormality is partly mediated by a pertussis toxin-insensitive altered guanosine triphosphate-binding protein.
- Persistent PMN dysfunction correlates with multiple system organ failure in severe pancreatitis patients.